Brandywine Global Investment Management’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $32.3M | Sell |
|
|||||
|
2025
Q2 | $29.9M | Buy |
|
|||||
|
2025
Q1 | $31.2M | Sell |
|
|||||
|
2024
Q4 | $28.1M | Buy |
|
|||||
|
2024
Q1 | – | Sell |
|
|||||
|
2023
Q4 | $25.5M | Buy |
|
|||||
|
2023
Q3 | $23.7M | Sell |
|
|||||
|
2023
Q2 | $33M | Sell |
|
|||||
|
2023
Q1 | $32.9M | Sell |
|
|||||
|
2022
Q4 | $33.7M | Sell |
|
|||||
|
2022
Q3 | $28.7M | Sell |
|
|||||
|
2022
Q2 | $35.1M | Sell |
|
|||||
|
2022
Q1 | $37.4M | Sell |
|
|||||
|
2021
Q4 | $33.9M | Sell |
|
|||||
|
2021
Q3 | $54.8M | Buy |
|
|||||
|
2021
Q2 | $28.3M | Buy |
|
|||||
|
2021
Q1 | $21.2M | Buy |
|
|||||
|
2020
Q4 | $13.3M | Sell |
|
|||||
|
2020
Q3 | $16.9M | Sell |
|
|||||
|
2020
Q2 | $16.5M | Sell |
|
|||||
|
2020
Q1 | $21M | Sell |
|
|||||
|
2019
Q4 | $48.6M | Sell |
|
|||||
|
2019
Q3 | $44.4M | Sell |
|
|||||
|
2019
Q2 | $42.9M | Buy |
|